Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376.

Geahča maid

• In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes.
  Dahkki: Speiser, D, et al.
  Almmustuhtton: (1999)
• CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients.
  Dahkki: Speiser, D, et al.
  Almmustuhtton: (1999)
• Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes.
  Dahkki: Romero, P, et al.
  Almmustuhtton: (1998)
• High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals.
  Dahkki: Pittet, M, et al.
  Almmustuhtton: (1999)
• Differences in phenotype and function between spontaneously occurring melan-A-, tyrosinase- and influenza matrix peptide-specific CTL in HLA-A*0201 melanoma patients.
  Dahkki: Maczek, C, et al.
  Almmustuhtton: (2005)